A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand R Ragupathy, K Aaltonen, J Tordoff, P Norris, D Reith Pharmacoeconomics 30, 1051-1065, 2012 | 50 | 2012 |
The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand K Aaltonen, R Ragupathy, J Tordoff, D Reith, P Norris Value in Health 13 (1), 148-156, 2010 | 39 | 2010 |
Cost-related barriers to use of health services and prescription medicines in Finland: a cross-sectional survey K Aaltonen, J Miettinen, I Airio, JE Martikainen, LK Saastamoinen, JS Bell, ... The European Journal of Public Health 25 (3), 368-372, 2015 | 23 | 2015 |
Growth of diabetes drug expenditure decomposed—a nationwide analysis A Soppi, P Heino, T Kurko, T Maljanen, L Saastamoinen, K Aaltonen Health Policy 122 (12), 1326-1332, 2018 | 19 | 2018 |
Health registers as a source of data for research and policy making LK Saastamoinen, K Aaltonen, T Maljanen, U Tuominen, JE Martikainen Dosis 28 (2012): 3, 2012 | 18 | 2012 |
Terveyserot K Aaltonen, S Kotimäki, L Salonen, E Tenhunen Teoksessa M. Mattila (toim.): Eriarvoisuuden tila Suomessa, 65-90, 2020 | 13 | 2020 |
The impact of a co-payment increase on the consumption of type 2 antidiabetics–A nationwide interrupted time series analysis H Rättö, T Kurko, JE Martikainen, K Aaltonen Health Policy 125 (9), 1166-1172, 2021 | 12 | 2021 |
The effect of pharmaceutical co-payment increase on the use of social assistance—A natural experiment study H Rättö, K Aaltonen PloS one 16 (5), e0250305, 2021 | 10 | 2021 |
From systemic hormone therapy to vaginal estrogen–A nationwide register study in Finland, 2003–2012 E Holm, K Aaltonen, AM Heikkinen, M Tiihonen Maturitas 78 (4), 293-297, 2014 | 10 | 2014 |
Trends and income related differences in out-of-pocket costs for prescription and over-the-counter medicines in Finland from 1985 to 2006 K Aaltonen, M Niemelä, P Norris, JS Bell, S Hartikainen Health Policy 110 (2-3), 131-140, 2013 | 9 | 2013 |
Toimeentulotuen saajien lääkekorvausoikeudet ja lääkkeiden käyttö K Aaltonen, K Lekander, E Ahola, H Hiilamo Sosiaalilääketieteellinen Aikakauslehti 55 (4), 321–334, 2018 | 8 | 2018 |
Can people afford to pay for health care: New evidence on financial protection in Finland J Tervola, K Aaltonen, F Tallgren WHO Regional Office for Europe, 2021 | 7 | 2021 |
Estimating the economic effects of pharmaceutical reimbursement scheme reform by microsimulation K Aaltonen, P Heino, E Ahola, JE Martikainen Research on Finnish Society 10 (1), 23-33, 2017 | 7 | 2017 |
Affordability of medicines from the pharmaceutical system perspective: Comparative analysis of Finland and New Zealand K Aaltonen Kela, 2017 | 7 | 2017 |
Kenellä ei ole varaa lääkkeisiin K Aaltonen, J Miettinen, LK Saastamoinen, J Martikainen Toimeen tuloturvan verkkoa kokemassa. Kansalaisten käsitykset ja odotukset …, 2013 | 7 | 2013 |
Kotitalouksien terveysmenojen vaikutukset köyhyyteen Suomessa J Tervola, K Aaltonen, P Heino, M Kajantie, H Kari, J Ollonqvist Turun yliopisto, 2019 | 6 | 2019 |
Income differences in the type of antihypertensive medicines used in ambulatory settings in Finland: a register-based study H Mirva, T Johanna, T Jussi, K Aaltonen European journal of clinical pharmacology 71, 1263-1270, 2015 | 6 | 2015 |
Kelan sairaanhoitokorvaukset tuloryhmittäin: Kenelle korvauksia maksetaan ja kuinka paljon? J Blomgren, K Aaltonen, J Tervola, L Virta Kela, 2015 | 6 | 2015 |
Toimeentulotuen käyttö terveys-ja lääkemenoihin Helsingissä 2008–2010 K Aaltonen, E Ahola, J Martikainen Teoksessa E. Ahola & H. Hiilamo (toim.) Köyhyyttä Helsingissä …, 2008 | 6 | 2008 |
Analysing the Effects of Healthcare Payment Policies on Poverty: A Microsimulation Study with Real-World Healthcare Data K Aaltonen, J Tervola, P Heino International Journal of Microsimulation 16 (1), 89-107, 2023 | 5 | 2023 |